Wart Remover Liquid

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the removal of corns, calluses, plantar warts, flat warts, and common warts that are less than 5 mm in size.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed thoroughly prior to treatment. The wart must be soaked in warm water for 5 minutes, after which it should be dried completely. Using the provided applicator, one drop of the medication should be applied at a time to ensure complete coverage of each wart. After application, the area should be allowed to dry. If desired, self-adhesive cushioning pads may be used to cover the wart.

This process may be repeated once or twice daily as needed, for a maximum duration of 12 weeks, until the wart is effectively removed. It is important to note that this medication is for external use only and must not be applied to healthy skin.

Contraindications

Use of this product is contraindicated in patients with diabetes due to potential complications associated with glycemic control. Additionally, it should not be used in individuals with poor circulation on irritated skin or in areas that are infected or reddened, including moles, birthmarks, warts with hair growing out of them, genital warts, or warts on the face or mucous membranes, as these conditions may exacerbate adverse effects.

This product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is advised.

Warnings and Precautions

For external use only. This product should be kept away from heat or flame to prevent any potential hazards. It is imperative to keep this product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact a Poison Control Center without delay.

Healthcare professionals should advise patients to discontinue use and consult a physician if they have diabetes. Additionally, patients should be instructed to stop use and seek medical advice if they experience poor circulation, irritation on the skin, or if the product is applied to any area that is infected or reddened. This includes moles, birthmarks, warts with hair growing out of them, genital warts, or warts located on the face or mucous membranes. Monitoring for these conditions is essential to ensure patient safety and effective use of the product.

Side Effects

Patients should be aware that the product is intended for external use only and should be kept away from heat or flame to prevent any potential hazards.

In clinical practice, patients are advised to stop using the product and consult a healthcare professional if they have diabetes or if they experience poor circulation on irritated skin. This includes any area that is infected or reddened, as well as on moles, birthmarks, warts with hair growing out of them, genital warts, or warts located on the face or mucous membranes. These precautions are essential to ensure the safety and well-being of individuals using the product.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Wart Remover Liquid (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients.

It is advisable to monitor elderly patients closely for any potential adverse effects or changes in therapeutic response, given the lack of targeted data for this population. Consideration of individual patient factors, including comorbidities and concurrent medications, is essential in managing treatment effectively.

Pregnancy

The safety of this product during pregnancy has not been established. Salicylic acid is contraindicated in pregnancy due to potential risk to the fetus. Pregnant women should avoid using this product unless directed by a healthcare provider. It is essential for healthcare professionals to weigh the potential risks against the benefits when considering treatment options for pregnant patients.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or lactation considerations. Healthcare professionals should exercise caution when prescribing this medication to lactating mothers, as the effects on breastfed infants are not well characterized. It is advisable to weigh the potential benefits against any unknown risks when considering treatment options for lactating patients.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may indicate an overdose. These may include, but are not limited to, increased severity of known side effects, unusual behavioral changes, or any other atypical clinical manifestations.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. It is recommended that healthcare professionals consult local poison control centers or relevant toxicology resources for specific guidance on the management of overdose cases.

In summary, while specific overdosage information is not available, healthcare professionals should exercise caution, monitor for symptoms, and provide appropriate supportive care in the event of an overdose.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Patients with diabetes should be informed of the potential risks associated with using this product. Additionally, it is important to discuss the implications of using the product on areas with poor circulation, irritated skin, or any infected or reddened areas, including moles, birthmarks, warts with hair growing out of them, genital warts, or warts on the face or mucous membranes.

When using this product, patients should be cautioned to avoid contact with the eyes, ears, and mouth. In the event that the product comes into contact with the eyes, patients should be instructed to flush the eyes with water for at least 15 minutes and seek medical attention if irritation persists.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers. It should be stored at a temperature range of 20° to 25°C (68° to 77°F). It is essential to keep the container tightly closed to maintain the integrity of the product. Special handling requirements include ensuring that the product is not exposed to extreme temperatures or humidity.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Wart Remover Liquid, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)